Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 2
2009 1
2010 2
2011 1
2013 2
2014 1
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration.
Newby LK, Rodriguez I, Finkle J, Becker RC, Hicks KA, Hausner E, Chesler R, Harper C, Targum S, Berridge BR, Lewis E, Walker DB, Dollery C, Turner JR, Krucoff MW. Newby LK, et al. Among authors: harper c. Am Heart J. 2011 Jul;162(1):64-73. doi: 10.1016/j.ahj.2011.04.005. Am Heart J. 2011. PMID: 21742091 Review.
FDA perspectives on pharmacogenetic testing.
Harper CC, Philip R, Robinowitz M, Gutman SI. Harper CC, et al. Expert Rev Mol Diagn. 2005 Sep;5(5):643-8. doi: 10.1586/14737159.5.5.643. Expert Rev Mol Diagn. 2005. PMID: 16149867
Rationale for the tinnitus retraining therapy trial.
Formby C, Scherer R; TRTT Study Group. Formby C, et al. Noise Health. 2013 Mar-Apr;15(63):134-42. doi: 10.4103/1463-1741.110299. Noise Health. 2013. PMID: 23571304 Free PMC article. Clinical Trial.
Development and regulatory strategies for drug and diagnostic co-development.
Hinman LM, Carl KM, Spear BB, Salerno RA, Becker RL, Abbott BM, Kelly JF, Mansfield E, Katz RG, Harper C, Day SP, Pacanowski MA, Pignato W. Hinman LM, et al. Among authors: harper c. Pharmacogenomics. 2010 Dec;11(12):1669-75. doi: 10.2217/pgs.10.141. Pharmacogenomics. 2010. PMID: 21142909
The Tinnitus Retraining Therapy Trial (TRTT): study protocol for a randomized controlled trial.
Scherer RW, Formby C, Gold S, Erdman S, Rodhe C, Carlson M, Shade D, Tucker M, Sensinger LM, Hughes G, Conley GS, Downey N, Eades C, Jylkka M, Haber-Perez A, Harper C, Russell SK, Sierra-Irizarry B, Sullivan M; Tinnitus Retraining Therapy Trial Research Group. Scherer RW, et al. Among authors: harper c. Trials. 2014 Oct 15;15:396. doi: 10.1186/1745-6215-15-396. Trials. 2014. PMID: 25319676 Free PMC article. Clinical Trial.
BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.
Stryke D, Kawamoto M, Huang CC, Johns SJ, King LA, Harper CA, Meng EC, Lee RE, Yee A, L'Italien L, Chuang PT, Young SG, Skarnes WC, Babbitt PC, Ferrin TE. Stryke D, et al. Among authors: harper ca. Nucleic Acids Res. 2003 Jan 1;31(1):278-81. doi: 10.1093/nar/gkg064. Nucleic Acids Res. 2003. PMID: 12520002 Free PMC article.
15 results